Risperidone oral liquid
From 1 July 2014, PHARMAC is making some changes to the funded brands of risperidone oral liquid.
What is changing?
There are currently three funded brands of this medication available.
If you take either Apo-Risperidone or the Risperdal brand you will need to change to the Risperon brand of risperidone oral liquid.
When will the change happen
- From 1 September 2014 a part payment may be required for the risperidone brand you are taking unless you are already taking Risperon. To avoid this part payment, you will need to take the fully funded Risperon brand.
- From 1 December 2014, only the Risperon brand will be funded.
Will the medicine work in the same way?
Your medicine itself is not changing, only the brand. The funded brand of risperidone oral liquid contains the same amount of the active ingredient, risperidone. This means that the effect of the medicine Risperon should be the same as the brand you are currently taking.
You shouldn’t notice any difference in how you feel after taking Risperon. If you do notice any major changes or side effects, please talk with your doctor about it.
Will there be any additional costs for me to pay after 1 December?
Other than the usual patient co-payment, there will be no extra cost for you to pay if you take the funded brand (Risperon).
Will the tablets or pack look different?
Risperon is made by a different supplier and will look different, but will still have the same active medicine and will work in the same way. The Risperon oral liquid pack, bottle and liquid measurer are illustrated below.
Why has this change happened?
Recently a decision was made to fund only one brand of risperidone oral liquid. This means from 1 December only the Risperon brand of risperidone oral liquid will be fully funded. Significant savings are associated with the move to one fully-funded brand of risperidone oral liquid. This means that more money can be freed up to fund other medicines to treat other people in our communities. Rest assured, the Risperon oral liquid has been approved by Medsafe.
Where can I get more information?
If you would like more information about the change please contact the PHARMAC helpline, 0800 66 00 50 (between 9 am and 5 pm weekdays). You can also e-mail email@example.com with your queries or comments.
Your doctor, nurse or pharmacist will also help guide you during the changeover period.
Last updated: 4 July 2016